Market Newsdesk

NEW YORK, Dec. 19, 2020 (GLOBE NEWSWIRE) — Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies:

TC PipeLines, LP (NYSE: TCP)
concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to TC Energy Corporation for 0.70 common shares of TC Energy for each publicly-held TCP common unit. If you are a TCP shareholder, click here to learn more about your rights and options.

Cardtronics plc (NASDAQ: CATM)
concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to funds managed by affiliates of Apollo Global Management, Inc. and Hudson Executive Capital LP for $35.00 per share in cash. If you are a Cardtronics shareholder, click here to learn more about your rights and options.

MTS Systems Corporation (NASDAQ: MTSC)
concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to Amphenol Corporation for $58.50 per share in cash. If you are an MTS shareholder, click here to learn more about their legal rights and options.

CounterPath Corporation (NASDAQ: CPAH)
concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to Alianza, Inc. for $3.49 per share. If you are a CounterPath shareholder, click here to learn more about your rights and options.

Halper Sadeh LLP may seek increased consideration, additional disclosures and information concerning the proposed transaction, or other relief and benefits on behalf of shareholders.

Shareholders are encouraged to contact the firm free of charge to discuss their legal rights and options. Please call Daniel Sadeh or Zachary Halper at (212) 763-0060 or email [email protected] or [email protected].

Halper Sadeh LLP represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:
Halper Sadeh LLP
Daniel Sadeh, Esq.
Zachary Halper, Esq.
(212) 763-0060
[email protected]
[email protected]  

TORONTO, Dec. 19, 2020 (GLOBE NEWSWIRE) — SEIU (Services Employees International Union) Local 2 call for an immediate fair resolution of the Tropicana workers’ strike after a worker was violently assaulted on the picket line by a relation of a member of the Tropicana management team. The incident occurred on the picket line yesterday on Friday, December 18^th.

The assailant was a sibling of Tropicana’s HR manager. While leaving the property premises, the assailant got agitated and first tried to run through the picketers with her car several times before exiting the vehicle, screaming, “I’m going to [expletive] run you over, move out of the way, you [expletive].”

Workers tried to deescalate the situation and called the police, but the assailant fixated on a nearby female worker. Without warning, the assailant punched and pushed this worker. The force of the attack threw the assaulted worker face-first across the concrete, causing her jeans to be ripped and her knee to be bloodied and swollen. As the worker lay on the ground, the assailant shouted, “you [expletive] [expletive], Karen [Tropicana’s HR manager] gave you the job, you should be grateful, I’m going to end you.”

Simone Seelochan was one of the 22 witnesses at the scene. Seelochan says: “I have never witnessed something so aggressive and violent. We have been out in the cold chanting peacefully for 6 weeks straight meeting all kinds of people and they were all kind.”

She continues, “To be violated in such a physical way has left us all shaken. Her threats and abuse are an extension of how management treats their staff. Management has been telling us for so long that we deserve nothing but crumbs now we’re being beaten into believing it.”

Tropicana management’s intransigence is responsible for placing workers on the picket line, forcing them out during a worsening pandemic and in cold weather. This situation always held potential for adverse results, and SEIU Local 2 holds Tropicana management responsible for the violent incident yesterday. After six weeks of picketing, it’s time that Tropicana bring workers back to work and end the years of unfair wage freezes that engendered this strike.

SEIU Local 2 represents workers in Nova Scotia, Ontario, Alberta, New Brunswick and British Columbia.

Contact: Assya Moustaqim-Barrette
[email protected]
416-274-4903

PHILADELPHIA, Dec. 19, 2020 (GLOBE NEWSWIRE) — Kehoe Law Firm, P.C. is investigating potential securities claims on behalf of investors of GoodRx Holdings, Inc. (“GoodRx” or the “Company”) (NASDAQ: GDRX) to determine whether the Company engaged in securities fraud or other unlawful business practices.

GOODRX INVESTORS WHO PURCHASED, OR OTHERWISE ACQUIRED, THE COMPANY’S SECURITIES BETWEEN SEPTEMBER 23, 2020 AND NOVEMBER 16, 2020, BOTH DATES INCLUSIVE (THE “CLASS PERIOD”), AND SUFFERED SIGNIFICANT LOSSES

ARE ENCOURAGED TO COMPLETE KEHOE LAW FIRM’S

SECURITIES CLASS ACTION QUESTIONNAIRE

OR CONTACT MICHAEL YARNOFF, ESQ., (215) 792-6676, EXT. 804,

[email protected]

,

[email protected]

,

[email protected]

, TO DISCUSS THE 

SECURITIES CLASS ACTION


INVESTIGATION

OR POTENTIAL LEGAL CLAIMS.

A class action lawsuit has been filed seeking to recover damages on behalf of GoodRx investors who purchased, or otherwise acquired, GoodRx securities during the Class Period and suffered losses.

According to the class action complaint, at the time of GoodRx’s September 2020 Initial Public Offering (“IPO”), unbeknownst to investors, Amazon.com, Inc. (“Amazon”) was developing and would soon introduce its own online and mobile prescription medication ordering and fulfillment service that would directly compete with GoodRx.

The complaint alleges that the GoodRx Defendants timed the IPO so that it was priced before Amazon announced its online pharmaceutical business to facilitate the IPO and create artificial demand for the common shares sold therein, as well to maximize the amount of money the Company and the selling stockholders could raise in the IPO. Given the GoodRx Defendants’ knowledge of Amazon’s intention to enter the online pharmaceutical business, and their misleading statements about GoodRx’s competitive position made contemporaneously with that knowledge, the GoodRx Defendants’ allegedly made materially false and/or misleading statements and caused GoodRx common stock to trade at artificially inflated prices during the Class Period.

The class action complaint alleges that on November 17, 2020, just weeks after GoodRx completed its IPO, Amazon announced two new pharmacy offerings, a Prime Rx plan and a discount card program, which, among other things, would compete directly with GoodRx’s platform by making it “simple for customers to compare prices and purchase medications for home delivery, all in one place.”

On this news, according to the complaint,
the price of GoodRx common stock declined 23%, from $46.72 per share to $36.21 per share by the close of the market on November 17, 2020, erasing more than $4 billion of GoodRx’s market capitalization, thereby damaging GoodRx investors.

Kehoe Law Firm, P.C., with offices in New York and Philadelphia, is a multidisciplinary, plaintiff–side law firm dedicated to protecting investors from securities fraud, breaches of fiduciary duties, and corporate misconduct.  Combined, the partners at Kehoe Law Firm have served as Lead Counsel or Co-Lead Counsel in cases that have recovered more than $10 billion on behalf of institutional and individual investors.   

This press release may constitute attorney advertising.

PHILADELPHIA, Dec. 19, 2020 (GLOBE NEWSWIRE) — Kaskela Law LLC announces that it is investigating Decision Diagnostics Corp. (“Decision Diagnostics”) (OTC: DECN) on behalf of the company’s stockholders.

On December 17, 2020, the U.S. Securities and Exchange Commission (“SEC”) filed a complaint against Decision Diagnostics and its Chief Executive Officer (“CEO”), Keith Berman, in the U.S. District Court for the Southern District of New York. The complaint alleges that Decision Diagnostics and Berman seized upon the Covid-19 global pandemic through a series of press releases that falsely claimed Decision Diagnostics had developed a finger prick blood test that could detect Covid-19 in less than a minute.

According to the complaint, from March 2020 to at least June 2020, Decision Diagnostics and Berman made false and misleading statements about the existence of Decision Diagnostics’ Covid-19 device and progress towards FDA emergency use authorization. As alleged, at the time of these claims, Decision Diagnostics lacked a proven method for detecting the virus and had no physical testing device. Further, its advisors had warned that the testing kit they were trying to manufacture would not work as Decision Diagnostics had described. The complaint also alleges that the statements created the misleading impression that the test was soon to be introduced to the market and led to surges in the price and trading volume of Decision Diagnostics’ stock.

Decision Diagnostics’ investors are encouraged to contact Kaskela Law LLC at https://kaskelalaw.com/case/decision-diagnostics-corp/ for additional information about this investigation and their legal rights and options.

Kaskela Law LLC represents investors in securities fraud, corporate governance, and merger & acquisition litigation. For additional information about Kaskela Law LLC please visit www.kaskelalaw.com. This notice may constitute attorney advertising in certain jurisdictions.

CONTACT:

D. Seamus Kaskela, Esq.
KASKELA LAW LLC
18 Campus Boulevard, Suite 100
Newtown Square, PA 19073
(484) 258 – 1585
(888) 715 – 1740
www.kaskelalaw.com
[email protected]

PHILADELPHIA, Dec. 19, 2020 (GLOBE NEWSWIRE) — Kaskela Law LLC announces that it is investigating SolarWinds Corp. (NYSE: SWI) (“SolarWinds”) on behalf of the company’s stockholders.

On December 13, 2020, Reuters reported that SolarWinds disclosed that “monitoring products it released in March and June of this year may have been surreptitiously tampered with in a ‘highly-sophisticated, targeted and manual supply chain attack by a nation state.’” Reuters also reported that the SolarWinds’ hack “was used to compromise the company’s emails” and possibly gather other data as well.

Following this news, shares of SolarWind’s stock declined $3.93 per share, or nearly 17% in value, to close on December 14, 2020 at $19.62 per share, on heavy trading volume.
Shares of the Company’s stock continued to decline in value over the following days as additional information about the hack was disclosed to investors.

SolarWinds shareholders are encouraged to contact Kaskela Law LLC (D. Seamus Kaskela, Esq.) at (484) 258 – 1585, or by email at [email protected] or online at https://kaskelalaw.com/case/solarwinds-corp/, for additional information about this investigation and their legal rights and options.

Kaskela Law LLC represents investors in securities fraud, corporate governance, and merger & acquisition litigation. For additional information about Kaskela Law LLC please visit www.kaskelalaw.com. This notice may constitute attorney advertising in certain jurisdictions.

CONTACT:

D. Seamus Kaskela, Esq.
KASKELA LAW LLC
18 Campus Boulevard, Suite 100
Newtown Square, PA 19073
(484) 258 – 1585
(888) 715 – 1740
www.kaskelalaw.com
[email protected]

NEW YORK, Dec. 19, 2020 (GLOBE NEWSWIRE) — Zhang Investor Law announces a class action lawsuit on behalf of shareholders who bought shares of Covia Holdings Corporation f/k/a Fairmount Santrol Holdings Inc. (“Covia”) (OTC: CVIAQ) (NYSE: CVIA) (NYSE: FMSA) between March 15, 2016 to June 29, 2020, inclusive (the “Class Period”).

To join the class action, go to http://zhanginvestorlaw.com/join-action-form/?slug=covia-holdings-corporation&id=2519 or call Sophie Zhang, Esq. toll-free at 800-991-3756 or email [email protected] for information on the class action.

如果您想加入这个集体诉讼案，请在这里提交您的信息。http://zhanginvestorlaw.com/join-action-form/?slug=covia-holdings-corporation&id=2519

According to the lawsuit, defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: Covia’s proprietary “value-added” proppants were not necessarily more effective than ordinary sand; Covia’s revenues, which were dependent on its proprietary “value-added” proppants, was based on misrepresentations; when Covia insiders raised this issue, defendants did not take meaningful steps to rectify the issue; and as a result, defendants’ statements about its business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.

If you wish to serve as lead plaintiff, you must move the Court no later than February 8, 2021.

Lead plaintiff status is not required to seek compensation.  You may retain counsel of your choice.  You may remain an absent class member and take no action at this time.

Zhang Investor Law represents investors worldwide. Attorney Advertising. Prior results do not guarantee similar outcomes.

Zhang Investor Law P.C.
99 Wall Street, Suite 232
New York, New York 10005
[email protected]
tel: (800) 991-3756

First Adult-use-Only Dispensary Opens In Illinois’ Third Largest City

CHICAGO, Ill., Dec. 19, 2020 (GLOBE NEWSWIRE) — Executives with Verano, a leading multi-state cannabis company, and Mayor Steve Chirico celebrated the opening of Zen Leaf Naperville, an adult-use only dispensary. The store, located at 1516 N. Naper Blvd., is at the main intersection of the suburb’s resurgent Ogden Avenue retail corridor and less than a half-mile from the Interstate 88 interchange. Naperville is the company’s fourth Zen Leaf dispensary storefront to open in Illinois, with plans to open several additional locations in the state.

“Naperville is a nationally renowned market for top retailers of every industry. We’re proud to open a flagship regional adult-use dispensary in this premier and award-winning community,” said George Archos, founder, chairman and CEO of both Verano and Zen Leaf. “Through the leadership of Mayor Chirico and the city council, the city is poised to realize the many benefits the fast-growing cannabis industry provides. The city will enjoy the economic and fiscal benefits, and adults will gain safe, convenient access to high-quality, regulated cannabis products at Zen Leaf’s unique and customer-focused dispensary.”

Zen Leaf Naperville is the first adult-use only dispensary, and second overall, to open in the city after the city council passed an opt-in ordinance in August 2020.

“I always believed that with responsible regulation Naperville would attract the best of the industry, and the team at Zen Leaf kept their promise and has opened a distinctive, first-class dispensary in our community,” said Mayor Chirico. “Despite the pandemic and economic uncertainty, Zen Leaf is just one of several prominent businesses opening new retail destinations at this Ogden Avenue retail gateway, further elevating its prominence as a thriving, regional retail destination.”

Zen Leaf Naperville took the place of a long-vacant restaurant. The dispensary has already created 30 new jobs in the community. City officials believe adult-use cannabis will generate significant local tax revenue in the years ahead.

To provide a quick, convenient shopping experience, customers can also place their order online at www.zenleafdispensaries.com, and the dispensary offers same-day, in-store pick up. The store has a cashless ATM feature available to facilitate a customer’s purchase using a debit card, enhancing convenience and reducing cash handling.

The dispensary has a mandatory mask policy in effect.

The new dispensary offers a comprehensive menu of cannabis products including concentrates, edibles, vaporizers, and flower. Customers must be 21 or older to enter the store or purchase product.

On January 1, 2020, Illinois became the eleventh state in the country to legalize the use of recreational cannabis. Illinois’ thriving cannabis market surpassed $917 million in combined sales through November and is expected to reach $1.2 billion by the end of the year. Zen Leaf Naperville is Verano’s twenty-first operational dispensary in its national portfolio to begin retail sales of medical or adult-use cannabis, with additional locations throughout the country under construction.

Zen Leaf Naperville is open from 9 AM to 9 PM Monday to Thursday, 9 AM to 10 PM Friday and Saturday, and 10 AM to 6 PM on Sunday.

###

About Verano:
Verano is a leading vertically-integrated multi-state cannabis operator in the U.S. An operator of licensed cannabis cultivation, processing and retail facilities, Verano is devoted to the ongoing development of communal wellness by providing responsible access to regulated cannabis products to the discerning high-end customer. Active in 12 U.S. states, with 21 active retail locations and approximately 440,000 square feet across its cultivation facilities, Verano has been profitable since it was founded. Verano produces a full suite of premium, artisanal cannabis products sold under its trusted portfolio of consumer brands: Encore™, Avexia™ and Verano™. Verano designs, builds and operates inimitable Zen Leaf™ branded dispensary environments that deliver a superior cannabis shopping experience in both medical and adult-use markets. Learn more at http://verano.holdings/

Contacts:

Investors



Verano

Aaron Miles
Head of Investor Relations
[email protected]

Media



Verano

David Spreckman
Sr. Director, Corporate Communications & Retail Marketing
[email protected]  

Financial Profiles

Debbie Douglas
[email protected]
949-375-3436

Attachment

• Mayor Chirico, of Naperville

NEW YORK, Dec. 19, 2020 (GLOBE NEWSWIRE) — Zhang Investor Law announces a class action lawsuit on behalf of shareholders who bought shares of Berry Corporation (NASDAQ: BRY) (a) pursuant and/or traceable to the Company’s initial public offering conducted on or about July 26, 2018 (the “IPO” or “Offering”); or (b) between July 26, 2018 and November 3, 2020, both dates inclusive (the “Class Period”).

 If you wish to serve as lead plaintiff, you must move the Court no later than January 21, 2021. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.  To join the class action, go to http://zhanginvestorlaw.com/join-action-form/?slug=berry-corporation&id=2501 or call Sophie Zhang, Esq. toll-free at 800-991-3756 or email [email protected] for information on the class action.

如果您想加入这个集体诉讼案，请在这里提交您的信息。http://zhanginvestorlaw.com/join-action-form/?slug=berry-corporation&id=2501

According to the lawsuit, defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: Berry had materially overstated its operational efficiency and stability; Berry’s operational inefficiency and instability would foreseeably necessitate operational improvements that would disrupt the Company’s productivity and increase costs; the foregoing would foreseeably negatively impact the Company’s revenues; and as a result, the Offering Documents and the Company’s public statements were materially false and/or misleading and failed to state information required to be stated therein.

Lead plaintiff status is not required to seek compensation.  You may retain counsel of your choice.  You may remain an absent class member and take no action at this time.

Zhang Investor Law represents investors worldwide. Attorney Advertising. Prior results do not guarantee similar outcomes.

Zhang Investor Law P.C.
99 Wall Street, Suite 232
New York, New York 10005
[email protected]
tel: (800) 991-3756